Guangzhou Kingmed Diagnostics Group Co Ltd (603882) — Capital Reinvestment Ratio
Guangzhou Kingmed Diagnostics Group Co Ltd (603882) has a Capital Reinvestment Ratio of 0.36x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥327.19 Million) in capital expenditures (CN¥117.61 Million). See 603882 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Guangzhou Kingmed Diagnostics Group Co Ltd Capital Reinvestment Ratio (2012–2025)
This chart tracks Guangzhou Kingmed Diagnostics Group Co Ltd's Capital Reinvestment Ratio across 14 annual periods.
Annual Capital Reinvestment Ratio for Guangzhou Kingmed Diagnostics Group Co Ltd (2012–2025)
Year-by-year Capital Reinvestment Ratio for Guangzhou Kingmed Diagnostics Group Co Ltd from 2012 to 2025. For live market cap and broader valuation context, see 603882 market cap overview.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.35x | CN¥1.20 Billion | CN¥423.46 Million | ▼ -28.5% |
| 2024 | 0.49x | CN¥906.35 Million | CN¥446.36 Million | ▼ -15.2% |
| 2023 | 0.58x | CN¥1.23 Billion | CN¥714.75 Million | ▲ +34.6% |
| 2022 | 0.43x | CN¥1.95 Billion | CN¥840.54 Million | ▼ -5.4% |
| 2021 | 0.46x | CN¥2.09 Billion | CN¥952.42 Million | ▲ +26.2% |
| 2020 | 0.36x | CN¥1.52 Billion | CN¥550.65 Million | ▼ -13.0% |
| 2019 | 0.42x | CN¥661.40 Million | CN¥274.92 Million | ▼ -36.4% |
| 2018 | 0.65x | CN¥529.62 Million | CN¥346.27 Million | ▼ -51.2% |
| 2017 | 1.34x | CN¥283.53 Million | CN¥379.85 Million | ▼ -8.9% |
| 2016 | 1.47x | CN¥292.14 Million | CN¥429.71 Million | ▼ -3.5% |
| 2015 | 1.52x | CN¥220.39 Million | CN¥335.89 Million | ▼ -23.1% |
| 2014 | 1.98x | CN¥225.97 Million | CN¥447.87 Million | ▲ +94.9% |
| 2013 | 1.02x | CN¥75.55 Million | CN¥76.82 Million | ▲ +53.2% |
| 2012 | 0.66x | CN¥88.44 Million | CN¥58.71 Million | — |